1. Home
  2. COLL vs FBMS Comparison

COLL vs FBMS Comparison

Compare COLL & FBMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • FBMS
  • Stock Information
  • Founded
  • COLL 2002
  • FBMS 1995
  • Country
  • COLL United States
  • FBMS United States
  • Employees
  • COLL N/A
  • FBMS 1078
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • FBMS Major Banks
  • Sector
  • COLL Health Care
  • FBMS Finance
  • Exchange
  • COLL Nasdaq
  • FBMS Nasdaq
  • Market Cap
  • COLL 910.2M
  • FBMS 1.1B
  • IPO Year
  • COLL 2015
  • FBMS N/A
  • Fundamental
  • Price
  • COLL $28.07
  • FBMS $33.81
  • Analyst Decision
  • COLL Strong Buy
  • FBMS Buy
  • Analyst Count
  • COLL 5
  • FBMS 2
  • Target Price
  • COLL $43.60
  • FBMS $45.00
  • AVG Volume (30 Days)
  • COLL 438.9K
  • FBMS 153.3K
  • Earning Date
  • COLL 05-08-2025
  • FBMS 04-23-2025
  • Dividend Yield
  • COLL N/A
  • FBMS 2.97%
  • EPS Growth
  • COLL 43.56
  • FBMS 2.09
  • EPS
  • COLL 1.86
  • FBMS 2.44
  • Revenue
  • COLL $631,449,000.00
  • FBMS $279,641,000.00
  • Revenue This Year
  • COLL $20.00
  • FBMS N/A
  • Revenue Next Year
  • COLL $3.93
  • FBMS $5.26
  • P/E Ratio
  • COLL $15.63
  • FBMS $13.80
  • Revenue Growth
  • COLL 11.41
  • FBMS N/A
  • 52 Week Low
  • COLL $27.28
  • FBMS $22.96
  • 52 Week High
  • COLL $42.29
  • FBMS $39.21
  • Technical
  • Relative Strength Index (RSI)
  • COLL 37.90
  • FBMS 6.03
  • Support Level
  • COLL $29.01
  • FBMS $34.42
  • Resistance Level
  • COLL $30.53
  • FBMS $36.57
  • Average True Range (ATR)
  • COLL 0.82
  • FBMS 0.73
  • MACD
  • COLL -0.10
  • FBMS -4.02
  • Stochastic Oscillator
  • COLL 5.73
  • FBMS 0.00

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About FBMS First Bancshares Inc.

First Bancshares Inc operates as a bank holding company. It offers various products and services such as deposit, including checking accounts, savings accounts, and time deposits account for individuals, businesses, associations and organizations, and governmental authorities. It also provides commercial and personal loans, including secured and unsecured loans, consumer loans, and loans for business expansion and purchase of equipment and machinery, and residential mortgage loans. The bank renders services like financial and wealth management, online internet banking, voice response telephone inquiry, safe deposit boxes, traveler's checks, and mobile deposit, and others. It operates in the Commercial/Retail Bank, Mortgage Banking, and Holding company segments.

Share on Social Networks: